Zhejiang University Thiotepa trial for meningeal-risk Glioblastoma

Clinical trial NCT07511725 was registered on ClinicalTrials.gov by Zhejiang University. The study examines Thiotepa as a therapeutic intervention for patients with meningeal-risk Glioblastoma, a serious form of brain cancer with involvement of the meninges. Trial registration includes standard elements: study title, intervention details, eligibility criteria, and anticipated enrollment.

Healthcare institutions and clinical investigators should verify whether this trial affects their patient populations or research programs. Patients with meningeal-spread Glioblastoma may be eligible for enrollment. The trial registration provides contact information and site locations for potential participation. Results from this study will be posted to ClinicalTrials.gov upon completion.